Interventions to Improve the HIV PrEP Cascade Among Methamphetamine Users

Completed · Not applicable

Conditions studied: HIV/AIDS, Adherence, Medication, Drug Use

In brief

Despite increasing knowledge about and use of PrEP nationally, HIV continues to have disproportionate impact among cisgender men and transgender persons who have sex with men and transgender persons (MSM/TG), with methamphetamine (meth)-users being at particularly high risk. Building on their preliminary work, the investigators will pilot text messaging and peer navigation interventions to support PrEP use among meth-using MSM/TG with potential to be cost-effective, scalable, and easily adaptable.

Key facts

Study ID

NCT03584282

Run by

University of Washington

People needed

21

Starts

2018-07-11

Expected to finish

2022-06-30

Last updated by the study team

2024-06-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Meets the clinic's eligibility criteria for PrEP
• 18 years of age or older
• HIV-negative
• Cisgender man or individual on the trans gender variant spectrum who has sex with men
• Ability to understand, read, and speak English
• Reports meth use in the past 3 months
• Has a cell phone able to send and receive text messages

You may not qualify if…

• PrEP use in the prior month,
• Discomfort or anxiety with regards to text messaging.
• Has any circumstances that, based on the study staff's opinion, would preclude provision of informed consent, make participation unsafe, or make it unlikely the participant would be able to participate for 6 months.

Where it is running

• Kelley-Ross One-Step PrEP — Seattle, Washington, United States
• Gay City — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.